- Presentations
- 2
- Markets
- 1
Erbitux is a brand of Cetuximab marketed by ImClone, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Cetuximab
- Brand owner
- ImClone
- Registered in
- United States
- Strengths and forms
- 100 mg/50 mL injection, 200 mg/100 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Erbitux 100 mg/50 mL injectionIntravenous Cold chain | ImClone | US FDA | Available on request |
| Erbitux 200 mg/100 mL injectionIntravenous Cold chain | ImClone | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Erbitux
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.